Scientist behind CRISPR twins sharply criticized in government probe, loses job
By Dennis Normile,
Science
| 01. 21. 2019
He Jiankui, the Chinese researcher who claimed to have edited the genomes of twin baby girls in a heritable way—and earned widespread condemnation for conducting a risky procedure with little potential benefit—deliberately sidestepped regulations, dodged oversight, and used fake ethical review documents in hopes of gaining “personal fame” for a worldwide first, according to preliminary results from a Chinese governmental investigation reported today.
In response to the news, the Southern University of Science and Technology in Shenzhen, China, announced it was rescinding He’s contract as an associate professor and terminating his teaching and research activities, effective immediately.
In November 2018, He claimed to have engineered the genomes of early embryos to give the girls and their descendants resistance to HIV, the virus that causes AIDS. The dubious achievement, which He described at a scientific meeting and in YouTube videos in the wake of media reports, relied on CRISPR, a genome-editing technique that has never before been used on human embryos that were then implanted. He’s experiment was swiftly condemned by researchers and ethicists within China and around the world who insisted...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...